ArtVentive Medical Group conducted its first animal study of its next generation of the ArtVentive Endoluminal Occlusion System (EOS Gen II). The EOS is designed for use in the peripheral vasculature and offers immediate and permanent vessel occlusion in arterial and venous settings.
Patients with in-hospital cardiac arrest (IHCA) have low survival rates—but why do some hospitals achieve higher survival than others?
Scientists at CBSET have presented preclinical evidence that the Manta Large Bore Vascular Closure Device (VCD) from Essential Medical successfully closed large bore arterial access without complication.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
At the Radiological Society of North America (RSNA) 2015 annual meeting, GE Healthcare unveiled its new Logiq E9 ultrasound system.
The Revolution CT, Revolution HD and Revolution EVO CT scanners are now offered with a wider range of capabilities to enable clinicians to have more options in tailored computed tomography (CT) solutions specifically designed to their needs.
Precision Image Analysis Inc. (PIA) announced a dramatic expansion of its capabilities as a provider of medical imaging services. Building on its ISO-9001:2008 certification for its Quality Management System, PIA has adopted and implemented comprehensive Core Lab protocols and procedures.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Toshiba America Medical Systems Inc. is now making mobile C-arms available to its customers in the United States through a new partnership with Ziehm Imaging Inc.
December 15, 2015 — At RSNA 2015, GE Healthcare showcased Viosworks, a new, advanced application to greatly simplify ...
Toshiba is making it easier to plan for system installation with Envision 360, the industry’s first interactive and real-time-customizable 3-D planning tool.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

Citing increased use of its Materialise Mimics Innovation Suite in hospitals and other clinical settings, Materialise NV announced investment in additional medical production capacity for its U.S. operations.
Heart Test Laboratories Inc. (HTL) announced the commencement of a clinical study, initiated by Mount Sinai Medical Center, New York, examining the MyoVista heart screening device.
December 14, 2015 — Vital Images Inc. announced a partnership with Stratasys Ltd., a 3-D printing and additive ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 14, 2015 — St. Jude Medical Inc. announced CE Mark approval for magnetic resonance (MR) conditional labeling ...
December 14, 2015 — As the field of interventional medicine grows, so do the challenges for clinicians to plan, guide ...
December 14, 2015 — The industry’s first seamless integration of interventional radiology (IR) and CT technology into ...